Company intelligence / Profile preview

IXICO

London, England, United Kingdomixico.com ↗

Ownership: Private
Employees: ~81
Development stage: Commercial

Overview

IXICO provides advanced AI-powered neuroimaging and biomarker analytics to support biopharmaceutical companies in the design, execution, and analysis of neurological clinical trials. The company has a strong track record in supporting hundreds of global CNS studies with its proprietary platforms. It does not develop therapeutics but enables precision insights into drug safety/efficacy through imaging endpoints.

Therapeutic areas: Neurology
Modalities: Device (imaging biomarkers, digital diagnostics)Digital health platform
Industry: Contract Research Organization

Partnerships

Works with leading pharmaceutical companies, innovative biotechs, academic consortia, non-profits; specific partners are not named in public sources but includes collaborations with major pharma on CNS trials.

Beyond the preview

Go deeper on IXICO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IXICO.

Explore the full profile